{"id":533104,"date":"2026-07-04T18:59:10","date_gmt":"2026-07-04T18:59:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/533104\/"},"modified":"2026-07-04T18:59:10","modified_gmt":"2026-07-04T18:59:10","slug":"scientists-just-unlocked-an-endless-army-of-cancer-fighting-cells-sciencealert","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/533104\/","title":{"rendered":"Scientists Just Unlocked an Endless Army of Cancer-Fighting Cells : ScienceAlert"},"content":{"rendered":"<p>The human immune system has evolved an incredible ability to fight off cancerous cells.<\/p>\n<p>One of the first lines of defense is a specialized white blood cell called a <a href=\"https:\/\/doi.org\/10.1016\/j.ccell.2026.01.020\" rel=\"nofollow noopener\" target=\"_blank\">macrophage<\/a>.<\/p>\n<p>Its name is derived from the Greek words for &#8220;big&#8221; and &#8220;eater&#8221;, and, as its name suggests, this type of cell has a fierce <a href=\"https:\/\/www.sciencealert.com\/watch-immune-cells-caught-on-video-eating-live-skin-cancer-cells\" rel=\"nofollow noopener\" target=\"_blank\">appetite<\/a> for  <a href=\"https:\/\/www.sciencealert.com\/cancer\" class=\"lar_link lar_link_outgoing\" data-linkid=\"73077\" data-postid=\"207226\" rel=\"nofollow noopener\" target=\"_self\">cancer<\/a>. <\/p>\n<p>Macrophages can even <a href=\"https:\/\/www.sciencealert.com\/your-blood-may-contain-an-evolutionary-relic-older-than-animals-themselves\" rel=\"nofollow noopener\" target=\"_blank\">sound an &#8220;eat me&#8221; alarm<\/a> from within tumors, kicking other immune players like T Cells into action.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/ie\/wp-content\/uploads\/2026\/07\/1783191548_254_0.jpg\" alt=\"YouTube Thumbnail\" tabindex=\"0\" role=\"button\" class=\"youtube-thumbnail-preview\" loading=\"lazy\"\/> frameborder=&#8221;0\u2033 allow=&#8221;accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share&#8221; referrerpolicy=&#8221;strict-origin-when-cross-origin&#8221; allowfullscreen&gt;<\/p>\n<p>They are a wonderful target for cancer research, but so far, next-generation therapies have largely failed to unlock their true potential.<\/p>\n<p>A team led by scientists at the University of Southern California (USC) may have at last found the key.<\/p>\n<p>They can now genetically engineer the cells that ultimately give rise to macrophages in the lab, or macrophage progenitor cells.<\/p>\n<p>These are not  <a href=\"https:\/\/www.sciencealert.com\/stem-cells\" class=\"lar_link lar_link_outgoing\" data-linkid=\"73034\" data-postid=\"207226\" rel=\"nofollow noopener\" target=\"_self\">stem cells<\/a>, but the cells that go on to form stem cells, and they seem to have a superpower up their sleeves:<\/p>\n<p>They can make copies of themselves over and over.<\/p>\n<p>&#8220;The prevailing view has been that long-term self-renewal in the blood system is primarily a property of the \u2026 stem cells that can generate any type of blood or immune cell,&#8221; <a href=\"https:\/\/stemcell.keck.usc.edu\/renewable-cell-source-for-cancer-immunotherapy-and-beyond\/\" rel=\"nofollow noopener\" target=\"_blank\">explains<\/a> biologist Qi-Long Ying at USC.<\/p>\n<p>&#8220;We found that, under the right conditions, [progenitors] can also self-renew, dividing extensively while keeping their identity and ability to produce functional immune cells.&#8221;<\/p>\n<p>&#8220;That gives us a scalable starting point for engineering cell therapies for cancer, infectious disease, and potentially many other conditions.&#8221;<\/p>\n<p>CAR-T is a famous and groundbreaking <a href=\"https:\/\/www.sciencealert.com\/boosted-natural-killer-cells-could-lead-to-off-the-shelf-cancer-immunotherapy\" rel=\"nofollow noopener\" target=\"_blank\">cancer therapy<\/a> that requires taking a patient&#8217;s <a href=\"https:\/\/www.sciencealert.com\/new-t-cell-therapy-kills-most-human-cancer-types-and-might-work-across-individuals\" rel=\"nofollow noopener\" target=\"_blank\">T cells<\/a>, genetically engineering them to better fight cancer, and then infusing them back into the body&#8217;s circulation.<\/p>\n<p>So far, versions of CAR-T have shown remarkable success, significantly extending the lives of patients in <a href=\"https:\/\/www.sciencealert.com\/experimental-drug-helped-cancer-patients-live-40-longer-in-clinical-trial\" rel=\"nofollow noopener\" target=\"_blank\">clinical trials<\/a>.\u00a0<\/p>\n<p>But while they work best for <a href=\"https:\/\/www.cancer.gov\/about-cancer\/treatment\/research\/car-t-cells\" rel=\"nofollow noopener\" target=\"_blank\">cancer in the blood<\/a>, they don&#8217;t work as well against solid tumors.<\/p>\n<p>Typically, macrophages are the most abundant immune cells within a cancerous mass, but they are more challenging to engineer in the lab.<\/p>\n<p>These white blood cells have also proven difficult to grow outside the human body, often failing to proliferate to necessary levels.<\/p>\n<p>What&#8217;s more, they are tricky to freeze and store long-term.<\/p>\n<p>But all hope is not lost for a therapy like CAR-M, which is similar to <a href=\"https:\/\/www.sciencealert.com\/woman-with-3-autoimmune-diseases-enters-remission-after-immune-reset\" rel=\"nofollow noopener\" target=\"_blank\">CAR-T<\/a>, but with macrophages instead of T-cells.<\/p>\n<p><a href=\"https:\/\/www.sciencealert.com\/newsletter?utm_source=promo_stargazing\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" width=\"642\" height=\"336\" src=\"https:\/\/www.newsbeep.com\/ie\/wp-content\/uploads\/2026\/06\/FOMO-1200x628-_Dont-miss-the-next-breakthrough_-cosmic-colourful-642x336.jpg\" alt=\"Subscribe to ScienceAlert's free fact-checked newsletter\" class=\"wp-image-201722\"   loading=\"lazy\"\/><\/a><\/p>\n<p>The progenitor cells of macrophages, called granulocyte-monocyte progenitors (GMPs), could be the ticket.<\/p>\n<p>Using mouse and human GMPs, Ying and colleagues have figured out exactly what these cells need to eat to grow, feeding them a complex mix of chemicals at very specific stages.<\/p>\n<p>The hope is that this endless supply of GMPs can now be used for future cancer immunotherapies.<\/p>\n<p>In the lab, engineered GMPs generated potent CAR-Ms.<\/p>\n<p>When these lab-grown GMPs were injected into mice with blood cancer and solid tumors, researchers found that the progenitor cells generated a steady supply of macrophages and other immune players.<\/p>\n<p>Unlike injected macrophages, these GMPs spread throughout the rodent body and stalled the cancer&#8217;s progression in blood and in solid tumors.<\/p>\n<p><img decoding=\"async\" width=\"1200\" height=\"315\" src=\"https:\/\/www.newsbeep.com\/ie\/wp-content\/uploads\/2026\/07\/GMPDistribution-1200x315.png\" alt=\"Scientists Just Unlocked an Endless Army of Cancer-Fighting Cells\" class=\"wp-image-207246\"   loading=\"lazy\"\/>Macrophages injected into mice did not proliferate around the body as GMPs did. (Yue et al., <a href=\"https:\/\/dx.doi.org\/10.1016\/j.cell.2026.05.043\" rel=\"nofollow noopener\" target=\"_blank\">Cell<\/a>, 2026)<\/p>\n<p>&#8220;This method for the expansion and engineering of GMPs opens the door to numerous translational applications, much like T cell expansion and engineering,&#8221; <a href=\"https:\/\/stemcell.keck.usc.edu\/renewable-cell-source-for-cancer-immunotherapy-and-beyond\/\" rel=\"nofollow noopener\" target=\"_blank\">says<\/a> biologist and collaborator Ravi Majeti from Stanford University.<\/p>\n<p>&#8220;We have already demonstrated engineering of these cells to drive multiple potent functions, and there is a lot more to be explored.&#8221;\u00a0<\/p>\n<p>Related: <a href=\"https:\/\/www.sciencealert.com\/new-immune-system-discovery-could-help-beat-a-sneaky-cancer-cell-trick\" rel=\"nofollow noopener\" target=\"_blank\">New Immune System Discovery Could Help Beat a Sneaky Cancer Cell Trick<\/a><\/p>\n<p>For many years, scientists have tried to determine which T cells are best to re-engineer for CAR-T therapies. This new research, however, suggests that targeting the progenitors of immune cells is a potentially better route to success, covering more bases all at once.<\/p>\n<p>&#8220;Our study suggests that the future of immunotherapy may depend not only on designing <a href=\"https:\/\/www.sciencealert.com\/newly-discovered-t-cells-could-rid-late-stage-cancer-patients-of-tumors\" rel=\"nofollow noopener\" target=\"_blank\">better CAR receptors<\/a>, but also on choosing the right developmental stage of the cell,&#8221; <a href=\"https:\/\/stemcell.keck.usc.edu\/renewable-cell-source-for-cancer-immunotherapy-and-beyond\/\" rel=\"nofollow noopener\" target=\"_blank\">concludes<\/a> Ying.<\/p>\n<p>The study is published in <a href=\"https:\/\/dx.doi.org\/10.1016\/j.cell.2026.05.043\" rel=\"nofollow noopener\" target=\"_blank\">Cell<\/a>.<\/p>\n<p class=\"has-text-align-left has-sciencealert-light-gray-background-color has-background\">This article was fact-checked by <a href=\"https:\/\/www.sciencealert.com\/michaelirving\" rel=\"nofollow noopener\" target=\"_blank\">Jess Cockerill<\/a> and edited by <a href=\"https:\/\/www.sciencealert.com\/michelle-starr\" rel=\"nofollow noopener\" target=\"_blank\">Michelle Starr<\/a>. While we pride ourselves on our process, we are only human. If you spot a mistake, <a href=\"https:\/\/www.sciencealert.com\/contact-us\" rel=\"nofollow noopener\" target=\"_blank\">please let us know<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"The human immune system has evolved an incredible ability to fight off cancerous cells. One of the first&hellip;\n","protected":false},"author":2,"featured_media":533105,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[61,60,2209,80],"class_list":["post-533104","post","type-post","status-publish","format-standard","has-post-thumbnail","category-technology","tag-ie","tag-ireland","tag-msft-content","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/533104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=533104"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/533104\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/533105"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=533104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=533104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=533104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}